Skip to main content

Table 1 Injection strategy of inhibitors for assessment of substrate oxidation dependency and capacity

From: A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell lines

Pathway

Measure

1st injection

2nd injection

Glucose

Dependency

UK5099

BPTES/etomoxir

Capacity

BPTES/etomoxir

UK5099

Glutamine

Dependency

BPTES

Etomoxir/UK5099

Capacity

Etomoxir/UK5099

BPTES

Palmitate

Dependency

Etomoxir

BPTES/UK5099

Capacity

BPTES/UK5099

Etomoxir